Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction

European Journal of Internal Medicine

Volumn 26, Issue 2, 2015, Pages 127-130

  Wald, David S ^a,b   Bangash, Fatima A ^a   Bestwick, Jonathan P ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

Familial; Hypercholesterolaemia; Myocardial infarction; Premature

Indexed keywords

DNA; LOW DENSITY LIPOPROTEIN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; EXON; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE DELETION; GENE DUPLICATION; GENE SEQUENCE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREVALENCE; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; COHORT ANALYSIS; COMORBIDITY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HYPERLIPOPROTEINEMIA TYPE II; MIDDLE AGED; MYOCARDIAL INFARCTION; ONSET AGE; PROSPECTIVE STUDY; RISK FACTOR; UNITED KINGDOM;

ADULT; AGE OF ONSET; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LONDON; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 84924273749     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2015.01.014     Document Type: Article

References (25)

1. World Health Organization Mortality Database http://www.who.int/healthinfo/mortality-data/en/ 2014 (accessed 18 August 2014)
2. J.L. Goldstein, H.H. Hobbs, and B. MS Familial hypercholesterolemia C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, The metabolic and molecular bases of inherited disease 1995 McGraw-Hill Companies New York, NY 1215 1245
3. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group Atherosclerosis 142 1 1999 12 105
4. National Institute for Health and Clinical Excellence Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. NICE clinical guideline 71 http://www.nice.org.uk/guidance/cg71 August 2008 (accessed 18 August 2014)
5. J.K. Morris, D.S. Wald, and N.J. Wald The evaluation of cascade testing for familial hypercholesterolemia Am J Med Genet A 158 1 2012 78 84 10.1002/ajmg.a.34368
6. S.A. Miller, D.D. Dykes, and H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 3 1988 1215
7. S.E. Humphries, R.A. Whittall, and C.S. Hubbart Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk J Med Genet 43 12 2006 943 949 10.1136/jmg.2006.038356
8. E. Usifo, S.E. Leigh, and R.A. Whittall Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment Ann Hum Genet 76 5 2012 387 401 10.1111/j.1469-1809.2012.00724.x (access date July 28 2014)
9. Royal College of Physicians Guidelines on the practice of ethics committees in medical research with human participants (Fourth edition) https://www.rcplondon.ac.uk/sites/default/files/documents/guidelines-practice-ethics-committees-medical-research.pdf September 2007 (accessed 28 November 2014)
10. F. Garwood Fiducial limits for the Poisson distribution Biometrika 28 3/4 1936 437 442 10.2307/2333958
11. M. Benn, G.F. Watts, A. Tybjaerg-Hansen, and B.G. Nordestgaard Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication J Clin Endocrinol Metab 97 11 2012 3956 3964 10.1210/jc.2012-1563
12. Health and Social Care Information Centre Health Survey for England-2012, trend tables http://www.hscic.gov.uk/catalogue/PUB13219 2012 (accessed 18 August 2014)
13. C.J. Clopper, and E.S. Pearson The use of confidence or fiducial limits illustrated in the case of the binomial Biometrika 26 4 1934 404 413 10.1093/biomet/26.4.404
14. U.M. Koivisto, L. Hämäläinen, and M.R. Taskinen Prevalence of familial hypercholesterolemia among young north Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction J Lipid Res 34 2 1993 269 277
15. J.L. Goldstein, W.R. Hazzard, and H.G. Schrott Hyperlipidemia in coronary heart disease I. lipid levels in 500 survivors of myocardial infarction J Clin Invest 52 7 1973 1533 1543 10.1172/JCI107331
16. E.A. Nikkila, and A. Aro Family study of serum lipids and lipoproteins in coronary heart-disease Lancet 1 7810 1973 954 959
17. L.S. Rallidis, J. Lekakis, and D. Panagiotakos Long-term prognostic factors of young patients (≤ 35 years) having acute myocardial infarction: the detrimental role of continuation of smoking Eur J Cardiovasc Prev Rehabil 15 5 2008 567 571 10.1097/HJR.0b013e32830774db
18. F. Wiesbauer, H. Blessberger, and D. Azar Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or = 40 years of age) Eur Heart J 30 9 2009 1073 1079 10.1093/eurheartj/ehp051
19. M.F. Dorsch, R.A. Lawrance, N.P. Durham, and A.S. Hall Familial hypercholesterolaemia is underdiagnosed after AMI BMJ 322 7278 2001 111 10.1136/bmj.322.7278.111
20. D. Patterson, and J. Slack Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives Lancet 1 7747 1972 393 399
21. World Health Organization Familial hypercholesterolemia - report of a second WHO consultation 1999 Geneva, Switzerland: World Health Organization (WHO publication no. WHO/HGN/FH/CONS/99.2)
22. National Institute for Health and Clinical Excellence Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease (NICE clinical guideline 181, July 2014) http://www.nice.org.uk/guidance/CG181/chapter/Key-priorities-for-implementation (accessed 18 August 2014)
23. N.J. Wald, M. Simmonds, and J.K. Morris Screening for future cardiovascular disease using age alone compared with multiple risk factors and age PLoS One 6 5 2011 e18742 10.1371/journal.pone.0018742
24. European guidelines on cardiovascular disease prevention in clinical practice (version 2012) Eur Heart J 33 2012 1635 1701
25. A. Taylor, D. Wang, and K. Patel Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project Clin Genet 77 6 2010 572 580 10.1111/j.1399-0004.2009.01356.x